SYNERGY: The Dartmouth Center for clinical and Translational Science
SYNERGY:达特茅斯临床和转化科学中心
基本信息
- 批准号:8743342
- 负责人:
- 金额:$ 66.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-26 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:Basic ScienceBiological SciencesBiologyClinical ResearchClinical SciencesDisciplineDiseaseEnsureFundingGoalsHealthHealth PolicyHealth Services ResearchHome environmentInstitutionInstructionInterdisciplinary EducationKnowledgeMedicineNamesPopulation ResearchProductivityRecording of previous eventsResearchResearch PersonnelResourcesScienceServicesTrainingTranslational ResearchTranslationsauthoritycareercareer developmentclinical caredesignimprovedmemberpopulation basedpopulation healthprogramssynergism
项目摘要
The overarching goal of this proposal is to support and enhance our institutionally-funded Dartmouth Center
for Clinical and Translational Science, called SYNERGY-an integrated home for clinical and translational
science at Dartmouth. Dartmouth launched SYNERGY in 2010, a Center built on Dartmouth's richly
collaborative and collegial culture, its interdisciplinary life sciences and health services research programs,
and its commitment to accelerating the translation of scientific knowledge into practice and improved
population health. Over the past two years, fueled by Dartmouth's resources, and by the "Center status" and
authority given by Dartmouth's leaders, SYNERGY has taken bold steps to begin to transform the
institution's landscape for clinical and translational research. We propose four overarching aims designed to
continue to expand our ability to conduct decisive science on the biology of disease and to use new and
existing knowledge to transform the practice of medicine and thus to improve health-locally, regionally and
nationally. Over the next five years we will: (1) strengthen SYNERGY to achieve greater interdisciplinary and
programmatic research synergism and efficiency and promote an institutional culture aimed at advancing
clinical and translational science; (2) ensure that SYNERGY investigators can easily and efficiently access
resources and services, and thus enhance their productivity; (3) expand and integrate training and career
development programs to build research focus and passion among trainees from diverse disciplines who aim
to build successful careers in clinical and translational research; and (4) create a Center for Translational
Population Research , a technical and analytic resource that harnesses the value of population-based
research across the spectrum from T l (basic research) to T4 (population research and health policy), as a
resource both for Dartmouth and forthe national CTSA consortium. Dartmouth is united to ensure that
SYNERGY will continue to transform the landscape for clinical and translational research locally, regionally,
and-as a member of the CTSA consortium-nationally, and thus to improve population health.
RELEVANCE (See instructions):
Dartmouth has a history of collaborative research and interdisciplinary education in the life sciences and
health services research that have led to the creation of Dartmouth's Center for Clinical and Translational
Science, named SYNERGY. As proposed in this application, SYNERGY will be expanded to support the
efficient and rapid translation of scientific findings into clinical care and improved population health.
该提案的总体目标是支持和增强我们由机构资助的达特茅斯中心
用于临床和转化科学,称为Synergy-An综合房屋用于临床和翻译
达特茅斯的科学。达特茅斯(Dartmouth)于2010年推出了Synergy
合作和合作文化,跨学科生活科学和卫生服务研究计划,
并致力于加速将科学知识转化为实践并改善
人口健康。在过去的两年中,达特茅斯的资源以及“中心地位”和
达特茅斯(Dartmouth
机构的临床和转化研究景观。我们提出了四个旨在的总体目标
继续扩大我们对疾病生物学的果断科学的能力,并使用新的和
现有的知识来改变医学实践,从而在区域,区域和
全国。在接下来的五年中,我们将:(1)增强协同作用以实现更大的跨学科和
程序化研究的协同作用和效率,并促进旨在促进的机构文化
临床和转化科学; (2)确保协同研究人员可以轻松有效地访问
资源和服务,从而提高其生产力; (3)扩展和整合培训和职业
开发计划,以从各种各样的学科中建立研究重点和热情的研究重点和热情
在临床和转化研究中建立成功的职业; (4)创建一个翻译中心
人口研究,一种技术和分析资源,可利用基于人群的价值
从T L(基础研究)到T4(人口研究和健康政策)的整个范围的研究,
达特茅斯和国家CTSA财团的资源。达特茅斯团结一致,以确保
协同作用将继续改变本地,区域性研究的临床和转化研究的景观
并作为CTSA联盟的成员,从而改善人口健康。
相关性(请参阅说明):
达特茅斯(Dartmouth)在生命科学和
卫生服务研究导致达特茅斯临床和转化中心的创建
科学,名为Synergy。如本应用程序所提出的那样,协同作用将扩展以支持
有效,快速地将科学发现转化为临床护理并改善了人口健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALAN I GREEN其他文献
ALAN I GREEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALAN I GREEN', 18)}}的其他基金
Reward circuit dysfunction, substance use disorder and schizophrenia: a preclinical fMRI-based connectivity study
奖赏回路功能障碍、物质使用障碍和精神分裂症:基于功能磁共振成像的临床前连通性研究
- 批准号:
9375636 - 财政年份:2017
- 资助金额:
$ 66.86万 - 项目类别:
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
大麻、精神分裂症和奖励:自我药疗和激动剂治疗?
- 批准号:
8632172 - 财政年份:2013
- 资助金额:
$ 66.86万 - 项目类别:
SYNERGY: The Dartmouth Center for clinical and Translational Science
SYNERGY:达特茅斯临床和转化科学中心
- 批准号:
9120444 - 财政年份:2013
- 资助金额:
$ 66.86万 - 项目类别:
SYNERGY: The Dartmouth Center for clinical and Translational Science
SYNERGY:达特茅斯临床和转化科学中心
- 批准号:
8721021 - 财政年份:2013
- 资助金额:
$ 66.86万 - 项目类别:
SYNERGY: The Dartmouth Center for clinical and Translational Science
SYNERGY:达特茅斯临床和转化科学中心
- 批准号:
8743341 - 财政年份:2013
- 资助金额:
$ 66.86万 - 项目类别:
SYNERGY: The Dartmouth Center for clinical and Translational Science
SYNERGY:达特茅斯临床和转化科学中心
- 批准号:
9274366 - 财政年份:2013
- 资助金额:
$ 66.86万 - 项目类别:
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
大麻、精神分裂症和奖励:自我药疗和激动剂治疗?
- 批准号:
8732617 - 财政年份:2013
- 资助金额:
$ 66.86万 - 项目类别:
SYNERGY: The Dartmouth Center for clinical and Translational Science
SYNERGY:达特茅斯临床和转化科学中心
- 批准号:
8721008 - 财政年份:2013
- 资助金额:
$ 66.86万 - 项目类别:
SYNERGY: The Dartmouth Center for clinical and Translational Science
SYNERGY:达特茅斯临床和转化科学中心
- 批准号:
8889745 - 财政年份:2013
- 资助金额:
$ 66.86万 - 项目类别:
Clozapine for Cannabis Use Disorder in Schizophrenia
氯氮平治疗精神分裂症大麻使用障碍
- 批准号:
8507191 - 财政年份:2012
- 资助金额:
$ 66.86万 - 项目类别:
相似国自然基金
基于图神经网络的大规模生物知识图谱预训练方法研究
- 批准号:62302100
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
分子细胞生物科学与技术发展战略研究(2021-2035)
- 批准号:
- 批准年份:2019
- 资助金额:50 万元
- 项目类别:专项基金项目
谷子雄性不育基因的遗传研究
- 批准号:38900031
- 批准年份:1989
- 资助金额:3.0 万元
- 项目类别:青年科学基金项目
相似海外基金
2023 Physiology, Biology and Pathology of Phosphate GRC
2023年磷酸盐GRC的生理学、生物学和病理学
- 批准号:
10608802 - 财政年份:2023
- 资助金额:
$ 66.86万 - 项目类别:
Biology at birth: the role of infancy in providing the foundation for lifetime success
出生时的生物学:婴儿期为终身成功奠定基础的作用
- 批准号:
10608856 - 财政年份:2023
- 资助金额:
$ 66.86万 - 项目类别:
2021 Mitochondria in Health and Disease Gordon Research Conference
2021 年线粒体健康与疾病戈登研究会议
- 批准号:
10236763 - 财政年份:2023
- 资助金额:
$ 66.86万 - 项目类别:
The Platelet Transcriptome and Organ Failure After Injury: Discovering Molecular Biomarkers and Preventative Targets through Interrogating Novel RNA Modifications
血小板转录组和损伤后器官衰竭:通过研究新的 RNA 修饰发现分子生物标志物和预防靶点
- 批准号:
10711791 - 财政年份:2023
- 资助金额:
$ 66.86万 - 项目类别: